Moderna Inc. Stock Slides 5.0%, Underperforms Peers
Dow Jones2026/10/12 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. slipped 5.0% to $213.74 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,850.55 and the NASDAQ Composite Index falling 0.4% to 27,245.90.
The stock's fall snapped a three-day winning streak.
Moderna Inc. closed 5.0% below its 52-week high of $225.00, which the company reached on October 9th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.9% to $263.73, Pfizer Inc. rose 0.4% to $28.40, and Gilead Sciences Inc. fell 0.49% to $150.43.
Trading volume totaled 12.8 million, compared to the 50-day average of 22.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 12, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bank of England hawkish official: Growth exceeds expectations and employment is resilient, which precisely proves that further rate hikes are necessary.
Megan Greene, a policymaker at the Bank of England, stated that the UK's economic growth surpassing expectations and the resilience of the job market indicate that the Bank of England's efforts to curb inflation are still insufficient.
24 Hour Crypto Recap: Here’s What Happened in the Market
AI investment is reshaping the bond market! Sunak: By 2027, the net issuance of long-term bonds by technology companies may surpass that of the US government
By 2027, tech companies are expected to become larger net issuers of long-term debt than the U.S. government.
Crypto prices
More
